You are on page 1of 9

MNPs utilisation in

Biomedical Applications
Chemistry & Characterisation of Thin Films & Surfaces

Asterios Ntais
MNPs - Introduction
Fe Co Ni Metal oxides
manipulation by external Magnetic Field
size ! biological components (drug delivery)
surface + magnetic moment (in vivo MRI)
absorbed energy into heat (hyperthermia)
colloidal stability | no agglomeration
Properties depend on:
magnetic anisotropy composition vacancies
crystal structure size shape
atomic magnetic dipole
(orbital + spin motion)
magnetic order (T
c
")

e
-
arrangements

magnetic behaviour

size ! 100nm:
1. single magnetic
domain
2. magnetisation
reversal = uniform
3. function of T
Synthesis of MNPs
1. Gas-phase methods (s-precipitates from g-phases)
CVD: volatile precursors high T (size & growth control)
Laser pyrolysis: thermochemical decomposition
ultrapure & high quality products | low yield

2. Wet chemical methods (simple, inexpensive, better yield)
Coprecipitation: precipitation of aqueous solution + base
Massart Method: alkaline coprecipitation of ferrous & ferric salt
pH, [cations], temperature dependent
Fe
3
O
4
, #-Fe
2
O
3
uniform size distribution | nucleation & growth


i.e. iron oxides from Fe(Co)
5

Synthesis of MNPs
3. Thermal decomposition (rapid process)
unstable precursors into hot-aqueous solution
organometallic & inorganic precursor, temperature, reaction time
complexes bound to iron via oxygen
surfactants (fatty acids) mediate nucleation & growth rates

4. Microemulsion
H
2
O nanodroplets in oil stabilised by surfactants

A, B reagents dissolved in 2 emulsions
mixing AB precipitation, trapped w/in H
2
O droplets
size and shape control
iron oxide NPs


Surface modification
need for chemical stability & functionalities - biofunctionalisation
high [protein] & [salt] environments
H
2
Ophilic / H
2
Ophobic
ligands & coatings (organic molecules, surfactants, polymers)
Avoid:
immune responses | protein synthesis failure
clotting | generation of ROS (!!!)
Main goals:
1. conservation of magnetic properties
2. increased biocompatibility decreased toxicity



Biomedical Apps of MNPs
Magnetic Hyperthermia
eliminate cancer cells @ 42 - 45
o
C (locally)
application of an AC magnetic field

Drug Delivery
MNPs: drug or antibody carriers to specific organs / tissues
fight w/ forces of blood flow
magnetic guidance
particle size: 10 100nm
surface engineering to minimise interactions w/ phagocytic cells




Energy loss HEAT
Biomedical Apps of MNPs
Magnetic Resonance Imaging
MNPs serve as contrast agents
need for high chemical stability and magnetisation
extensive use of maghemite (#-Fe
2
O
3
)
size ! 50nm: imaging of gastrointestinal, liver, spleen, lymph nodes
size " 50nm: diffusion imaging & brain / myocardial imaging

appropriate for enzyme activity imaging (apoptosis, cancer,
metastasis, inflammatory responses)

functionalisation of MNPs w/ monoclonal antibodies


Characterisaton techniques
X-Ray Diffraction
mapping of a material | chemical identification

Transmission Electron Scopy
structural characterisation @ atomic scale resolution

Fourier Transform Infrared Spectroscopy
fingerprint of a molecule
MNPs: size, shape, element, phase identification

Vibrating Sample Magnetometer
Faradays principle (a changing magnetic field produces an electric field)
delivers information about saturation magnetisation, coercivity, shape
anisotropy, energy loss


Thanx
Questions?

You might also like